Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
274.66
-8.42 (-2.97%)
At close: Aug 1, 2025, 4:00 PM
275.00
+0.34 (0.12%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Elevance Health Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$416.86
Upside
+51.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $492 → $297 | Hold | Maintains | $492 → $297 | +8.13% | Jul 25, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $472 → $384 | Buy | Maintains | $472 → $384 | +39.81% | Jul 22, 2025 |
| Barclays | Barclays | Buy Maintains $358 → $327 | Buy | Maintains | $358 → $327 | +19.06% | Jul 22, 2025 |
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 21, 2025 |
| UBS | UBS | Strong Buy Maintains $484 → $435 | Strong Buy | Maintains | $484 → $435 | +58.38% | Jul 18, 2025 |
| Barclays | Barclays | Buy Maintains $434 → $358 | Buy | Maintains | $434 → $358 | +30.34% | Jul 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $447 → $360 | Strong Buy | Maintains | $447 → $360 | +31.07% | Jul 18, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $428 → $316 | Buy | Maintains | $428 → $316 | +15.05% | Jul 18, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $510 → $310 | Buy → Hold | Downgrades | $510 → $310 | +12.87% | Jul 18, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $500 → $440 | Strong Buy | Maintains | $500 → $440 | +60.20% | Jul 16, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $478 → $400 | Buy | Maintains | $478 → $400 | +45.63% | Jul 15, 2025 |
| UBS | UBS | Strong Buy Maintains $555 → $484 | Strong Buy | Maintains | $555 → $484 | +76.22% | Jul 14, 2025 |
| Barclays | Barclays | Buy Maintains $480 → $434 | Buy | Maintains | $480 → $434 | +58.01% | Jul 9, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $510 → $500 | Strong Buy | Maintains | $510 → $500 | +82.04% | Jun 9, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $478 | Buy | Reiterates | $478 | +74.03% | Jun 4, 2025 |
| Barclays | Barclays | Buy Maintains $522 → $480 | Buy | Maintains | $522 → $480 | +74.76% | Jun 2, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.